When national businesses become global operations… With the industry sourcing more raw materials and services from around the world and distributing its products in new markets, companies are adapting their business processes to suit a more complex global operating environment.
22-Apr-2013 - DKSH has upgraded its cold chain infrastructure in Southeast Asia as both small and large manufacturers increase their access needs to emerging markets.
17-Apr-2013 - Globalisation, outsourcing and a move towards biopharmaceuticals are leading innovation for pharma distribution companies, according to DHL Global Forwarding.
17-Apr-2013 - DKSH has won a second deal with a Big Pharma firmin Asia in as many months, with US giant Pfizer signing up the firm as its agent in Cambodia.
15-Apr-2013 - An EMA report says increased Russian participation in European submitted clinical trials is part of a trend away from traditional regions, yet fluctuating legislation may affect numbers.
10-Apr-2013 - High drug industry demand for safety monitoring expertise drove Telerx’s acquisition of Sentrx Safety Solutions says deal broker.
26-Mar-2013 - Evonik gets the thumbs up from the MHRA, Recipharm's approved by Japan and Simcere passes the Chinese regulatory test – welcome to Outsourcing-Pharma’s round-up of GMP accreditation.
13-Mar-2013 - Catalent has penned a deal with CRO ShangPharma as part of a two-pronged plan into China and expects more investments to come.
13-Mar-2013 - Marken says the opening of its new pharma depot is part of a whole strategy within China and was driven by demand from an increase in clinical trials.
07-Mar-2013 - The CDSCO has started prescreening applications to register clinical trial ethics committees in a move designed to streamline the approval process.
05-Mar-2013 - US CRO PRA international has expanded its presence in Eastern Europe with the acquisition of privately-owned trial services firm ClinStar.
04-Mar-2013 - Following its acquisition of HCR, Synteract has become a multinational CRO with a presence in 16 countries.
21-Feb-2013 - CiToxLAB says strong revenue growth in 2012 was due to a new global status following its acquisition of Lab Research.
12-Feb-2013 - Swedish CRO Trial Form Support has announced plans to make its second late-stage, IT focused acquisition in the space of three months.
07-Feb-2013 - QPS has acquired Florida-based trial site Miami Research Associates (MRA), adding first-in-man capacity to its US services offering.
05-Feb-2013 - Clinical trials made public by Pfizer did not match internal reports or reflect what was done in studies of the seizure drug gabapentin say researchers calling for revision of journal...
16-Jan-2013 - Variation in site recruitment performance is a major risk factor for CROs and their sponsors according to new research.
15-Jan-2013 - PRA wants to build its late-phase offering in China and has committed to provide staff and knowhow to Wuxi Pharmatech joint venture.
15-Jan-2013 - Cambridge Major Labs’ (CML) new private-equity investor plans to expand the CMO’s chemistry and API business and assess cross selling synergies with other firms in its portfolio.
14-Jan-2013 - United Parcel Service (UPS) has abandoned its bid to buy Holland-based logistics firm TNT Express after the European Commission said it would block the deal.
09-Jan-2013 - Exela Pharma Sciences will invest $8.5million in its research and manufacturing plant in North Carolina. The venture, to be spread over the next three years, will provide 38 new jobs...
09-Jan-2013 - Swiss supplier Lonza has underlined its belief that ramping up complex manufacturing is key to improving the profitability of its Visp plant.
07-Jan-2013 - Australian CRO Clinical Network Services (CNS) has positioned itself as a “truly regional solution” with the acquisition of New Zealand-based Beltas.
07-Jan-2013 - Synteract will add trial capacity in Europe, Israel and South America through the acquisition of Munich-based Harrison Clinical Research. (HCR).
03-Jan-2013 - Parexel has acquired niche regulatory information management software firm Liquent and raised its guidance for 2013.
03-Jan-2013 - Local knowledge and global experience should be enough to see PRA and Wuxi PharmaTech buck the trend of failed China JVs, says analyst.